American College of PhysiciansComparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate vs. Alendronate Therapy

A new study has found that people with osteoporosis may experience less protection and be subject to more bone fractures when treated with the drug risedronate. Patients who were treated with risedronate during a drug holiday experienced more hip and other fractures than patients given other medications. Drug holidays are recommended after three to five […]

American Society of Clinical OncologyManagement of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Clinical Practice Guideline

A systematic review identified 204 eligible publications from 2000 through 2017, with much of the evidence consisting of systematic reviews of observational data, consensus guidelines, case series, and case reports. Due to the paucity of high-quality evidence on management of immune-related adverse events, recommendations are based on expert consensus.

MedPage TodayA COVID ‘Breathalyzer’: Not All Hot Air?

Since the onset of COVID-19, medical professionals have struggled to rapidly diagnose and determine whether someone has the respiratory illness. This issue is particularly acute in hospital intensive care units (ICUs) where doctors and nurses must triage patients based on the severity of their illnesses. Now, a “breathalyzer” test given to critically ill patients has […]